OTCMKTS:IPIX

Innovation Pharmaceutical Stock Insider Trading

etoro logo Buy IPIX
*Your capital is at risk
$0.0003
-0.0001 (-25.00%)
At Close: Jun 03, 2026

INNOVATION PHARMACEUTICAL Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 84.69M and sold 56.57M IPIX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 84.69M shares
Sell 56.57M shares
76% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Sep 01, 2019
Sell
Class A Common Stock
F-InKind
Harness Jane A.
Vice President
CEO / President 9 619
Value: $1K
Sep 01, 2019
Sell
Class A Common Stock
F-InKind
Harness Jane A.
Vice President
CEO / President 9 619
Value: $1K
Sep 01, 2019
Sell
Class A Common Stock
F-InKind
Bertolino Arthur Peter
President And Cmo
CEO / President 421 611
Value: $54.8K
Jan 29, 2019
Buy
Class B Common Stock
A-Award
Ehrlich Leo
CEO And Chairman
CEO / President 909 090
Value: $0
Jan 29, 2019
Buy
Stock Option (right to buy)
M-Exempt
Ehrlich Leo
CEO And Chairman
CEO / President 909 090
Value: $100.0K
Jan 29, 2019
Buy
Stock Option (right to buy)
M-Exempt
Ehrlich Leo
CEO And Chairman
CEO / President 909 090
Value: $100.0K
Jan 29, 2019
Buy
Class B Common Stock
A-Award
Ehrlich Leo
CEO And Chairman
CEO / President 909 090
Value: $0
Oct 12, 2018
Sell
Class A Common Stock
F-InKind
Harness Jane A.
Vice President
CEO / President 9 272
Value: $4K
Oct 12, 2018
Sell
Class A Common Stock
F-InKind
Harness Jane A.
Vice President
CEO / President 9 272
Value: $4K
Oct 12, 2018
Sell
Class A Common Stock
F-InKind
Bertolino Arthur Peter
President And Cmo
CEO / President 218 946
Value: $87.6K
Oct 12, 2018
Sell
Class A Common Stock
F-InKind
Bertolino Arthur Peter
President And Cmo
CEO / President 218 946
Value: $87.6K
Sep 01, 2018
Buy
Class A Common Stock
A-Award
Harness Jane A.
Vice President
CEO / President 58 394
Value: $0
Sep 01, 2018
Buy
Class A Common Stock
A-Award
Harness Jane A.
Vice President
CEO / President 58 394
Value: $0
Sep 01, 2018
Buy
Employee Stock Option (right to buy)
A-Award
Harness Jane A.
Vice President
CEO / President 172 987
Value: $68.8K
Sep 01, 2018
Buy
Employee Stock Option (right to buy)
A-Award
Bertolino Arthur Peter
President And Cmo
CEO / President 617 839
Value: $245.9K
Sep 01, 2018
Buy
Class A Common Stock
A-Award
Bertolino Arthur Peter
President And Cmo
CEO / President 1 066 667
Value: $0
Sep 01, 2018
Buy
Class A Common Stock
A-Award
Bertolino Arthur Peter
President And Cmo
CEO / President 1 066 667
Value: $0
Sep 01, 2018
Buy
Employee Stock Option (right to buy)
A-Award
Bertolino Arthur Peter
President And Cmo
CEO / President 617 839
Value: $245.9K
Sep 01, 2018
Buy
Employee Stock Option (right to buy)
A-Award
Harness Jane A.
Vice President
CEO / President 172 987
Value: $68.8K
Dec 22, 2017
Sell
Class A Common Stock
F-InKind
Bertolino Arthur Peter
President And Cmo
CEO / President 238 048
Value: $166.6K
Dec 22, 2017
Sell
Class A Common Stock
F-InKind
Bertolino Arthur Peter
President And Cmo
CEO / President 238 048
Value: $166.6K
Sep 01, 2017
Sell
Class A Common Stock
F-InKind
Harness Jane A.
Vice President
CEO / President 1 000
Value: $0
Sep 01, 2017
Sell
Class A Common Stock
F-InKind
Harness Jane A.
Vice President
CEO / President 1 000
Value: $0
Sep 01, 2017
Buy
Employee Stock Option (right to buy)
A-Award
Bertolino Arthur Peter
Pres. & Chief Medical Officer
Officer 617 839
Value: $438.7K
Sep 01, 2017
Sell
Class A Common Stock
F-InKind
Harness Jane A.
Vice President
CEO / President 6 056
Value: $4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT INNOVATION PHARMACEUTICAL
INNOVATION PHARMACEUTICAL
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovar...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE